Law and policy reform

MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report

29 Nov 2021

News Research

Answer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...

Brazilian House of Representatives approves bill to suspend patents: finally lives before profits?

9 Jul 2021

Medicine Equality Now! News

Two months ago, the Brazilian Senate approved a law project bill (Law Project 12/21) that allows the country to expand...

We can’t end AIDS without tackling patent abuse

25 Jan 2020

News Opinion

Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...

TEDWomen: Why are drug prices so high?

24 Jan 2020

News Opinion

Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...

The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries

23 Sep 2019

News Opinion Research

A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...

What’s wrong with IP rights? Protecting medicines from competition can be costly

22 Apr 2019

News

Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...

Civil society key in TRIPS flexibility implementation

5 May 2018

News

Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...